AMGEN INC — Director's Dealing 2022

Aug 23, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2022-08-22

Reporting Person: Williams R Sanders (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-22	Common Stock	S	200	$249.96	Disposed	5301	Direct

Footnotes

F1: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.